4//SEC Filing
Sorrento Therapeutics, Inc. 4
Accession 0000899243-17-002779
CIK 0000850261operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:44 PM ET
Size
8.2 KB
Accession
0000899243-17-002779
Insider Transaction Report
Form 4
SHAH JAISIM
Director
Transactions
- Purchase
Common Stock
2017-02-03$5.15/sh+10,000$51,500→ 102,631 total
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000850261
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:44 PM ET
- Size
- 8.2 KB